Fig. 2: Timeline for isolates collected from patient 14, showing genotype assignment based on genomic distance.

Resistance results, phenotype and therapeutic information, including treatment received are also shown. Month 0 begins at the time of collection of the first isolate available for our study. AMK amikacin, AZM azithromycin, ATM aztreonam, CFTR modulators, CLR clarithromycin, CST colistin, FOX cefoxitin, LVX levofloxacin, TMP-SXT trimethoprim-sulfamethoxazole, TM tobramycin.